SEC Tracker
Get the app

Inmune Bio INMB

Inmune Bio announces Ebstrocel updates

Item 7.01 Investor disclosure, Item 8.01 Other events

Form
8-K
Filed
Importance
Notable
  1. Entered Master Services Agreement with Uniphar for Ebstrocel distribution
  2. Submitted pre-MAA to UK MHRA for Ebstrocel
  3. Issued press releases on October 21, 2026

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Inmune Bio files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Fitlife Brands FTLF public float $51M, Jun 30, 2025
  2. Immucell ICCC public float $51M, Jun 30, 2025
  3. Cue Biopharma CUE public float $52M, Jun 30, 2025
  4. Avalo Therapeutics AVTX public float $54M, Jun 30, 2025
  5. Precision Biosciences DTIL public float $47M, Jun 30, 2025